Showing promise in the field of excess body fat management, retatrutide presents a different method. Unlike many current medications, retatrutide functions as a double agonist, at once engaging both GLP-like peptide-1 (GLP-1) and glucose-sensitive insulinotropic substance (GIP) sensors. The dual activation encourages multiple helpful effects, inclu